[1] Synnovation Therapeutics Launches with $102 Million to Advance Clinical-Stage Pipeline of Precision Therapies Targeting Highly
Validated Disease Pathways. Retrieved January 24, 2024 from https://www.synnovationtx.com/synnovationtherapeuticslauncheswith102milliontoadvanceclinical-stagepipelineofprecision